Article
Mintz IRA Update — PhRMA's 2025 Policy Agenda And The Industry's Crossroads With The IRA And Drug Pricing Reform
As US pharmaceutical manufacturers continue to lead biopharmaceutical research and development, they find themselves increasingly...
Mintz